Clinical Islet Transplantation After Allogeneic Orthotopic Liver Transplantation
- 1 March 1998
- journal article
- case report
- Published by Elsevier in Transplantation Proceedings
- Vol. 30 (2) , 309-311
- https://doi.org/10.1016/s0041-1345(97)01282-7
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- A COMPARISON OF TACROLIMUS (FK506) AND CYCLOSPORINE FOR IMMUNOSUPPRESSION AFTER CADAVERIC RENAL TRANSPLANTATION1Transplantation, 1997
- USE OF INTRAVENOUS FK506 TO TREAT ACUTE REJECTION IN SIMULTANEOUS PANCREAS-KIDNEY TRANSPLANT RECIPIENTS ON MAINTENANCE ORAL FK506Transplantation, 1997
- A MULTICENTER ANALYSIS OF THE FIRST EXPERIENCE WITH FK506 FOR INDUCTION AND RESCUE THERAPY AFTER PANCREAS TRANSPLANTATION1Transplantation, 1996
- THE EFFECT OF FK506 ON GLYCEMIC RESPONSE AS ASSESSED BY THE HYPERGLYCEMIC CLAMP TECHNIQUETransplantation, 1995
- TRANSCRIPTIONAL INHIBITION OF INSULIN BY FK506 AND POSSIBLE INVOLVEMENT OF FK506 BINDING PROTEIN-12 IN PANCREATIC β-CELLTransplantation, 1995
- HUMAN ISLET ISOLATION AND ALLOTRANSPLANTATION IN 22 CONSECUTIVE CASES 1, 2Transplantation, 1992
- Effect of FK506 on insulin secretion in normal dogsMetabolism, 1992
- IN VIVO EFFECT OF FK506 ON HUMAN PANCREATIC ISLETSTransplantation, 1991
- Pancreatic islet transplantation after upper abdominal exeriteration and liver replacementThe Lancet, 1990